Skip to main content

previous disabled Page of 5
and
Your search also matched 30 preview-only Content is preview-only when you or your institution have not yet subscribed to it.

By making our abstracts and previews universally accessible we help you purchase only the content that is relevant to you.
results, e.g.

P2 purinergic receptors regulate the progression of colorectal cancer

Include preview-only content
  1. Article

    Open Access

    Prognostic significance of platelet‑to‑albumin ratio in patients with nasopharyngeal carcinoma receiving concurrent chemoradiotherapy: a retrospective study of 858 cases

    Despite evidence supporting the high correlation of the novel platelet-to-albumin ratio (PAR) with survival in diverse malignancies, its prognostic relevance in nasopharyngeal carcinoma (NPC) remains underexpl...

    **n Hua, Fei Xu, Wei Shi, Zhi-Qing Long, **n Huang, Fang-Fang Duan in BMC Cancer (2024)

  2. Article

    Open Access

    The efficacy and safety of adding PD-1 blockade to induction chemotherapy and concurrent chemoradiotherapy (IC-CCRT) for locoregionally advanced nasopharyngeal carcinoma: an observational, propensity score-matched analysis

    Despite the success of PD-1 blockade in recurrent/metastatic nasopharyngeal carcinoma (NPC), its effect for locoregionally advanced NPC (LANPC) remains unclear. This study aimed to evaluate the benefit of addi...

    Ya-Nan **, Meng-Yun Qiang, Ying Wang, Yu-**g Lin in Cancer Immunology, Immunotherapy (2024)

  3. Article

    Open Access

    Dynamic genomic changes in methotrexate-resistant human cancer cell lines beyond DHFR amplification suggest potential new targets for preventing drug resistance

    Although DHFR gene amplification has long been known as a major mechanism for methotrexate (MTX) resistance in cancer, the early changes and detailed development of the resistance are not yet fully understood.

    **ang-Ning Meng, **-Fa Ma, Yang-He Liu, Si-Qing Li, Xu Wang in British Journal of Cancer (2024)

  4. Article

    Open Access

    Enhanced cellular therapy: revolutionizing adoptive cellular therapy

    Enhanced cellular therapy has emerged as a novel concept following the basis of cellular therapy. This treatment modality applied drugs or biotechnology to directly enhance or genetically modify cells to enhan...

    Meng-Yao Xu, Na Zeng, Chen-Qian Liu, Jian-Xuan Sun in Experimental Hematology & Oncology (2024)

  5. Article

    Open Access

    METTL14 downregulation drives S100A4+ monocyte-derived macrophages via MyD88/NF-κB pathway to promote MAFLD progression

    Without intervention, a considerable proportion of patients with metabolism‐associated fatty liver disease (MAFLD) will progress from simple steatosis to metabolism‐associated steatohepatitis (MASH), liver fib...

    Yue-fan Wang, Wen-li Zhang, Zhi-xuan Li in Signal Transduction and Targeted Therapy (2024)

  6. Article

    Open Access

    Enhancing therapeutic efficacy in luminal androgen receptor triple-negative breast cancer: exploring chidamide and enzalutamide as a promising combination strategy

    Extensive exploration of the molecular subtypes of triple-negative breast cancer (TNBC) is critical for advancing precision medicine. Notably, the luminal androgen receptor (LAR) subtype has attracted attentio...

    Ya-**n Zhao, Han Wang, Si-Wei Zhang, Wei-**n Zhang in Cancer Cell International (2024)

  7. Article

    Open Access

    Mex-3 RNA binding family member A (MEX3A)/circMPP6 complex promotes colorectal cancer progression by inhibiting autophagy

    RNA-binding proteins (RBPs)-RNA networks have contributed to cancer development. Circular RNAs (circRNAs) are considered as protein recruiters; nevertheless, the patterns of circRNA-protein interactions in col...

    Ri-**n Chen, Shui-Dan Xu, Min-Hua Deng in Signal Transduction and Targeted Therapy (2024)

  8. Article

    Open Access

    RNA modifications in cellular metabolism: implications for metabolism-targeted therapy and immunotherapy

    Cellular metabolism is an intricate network satisfying bioenergetic and biosynthesis requirements of cells. Relevant studies have been constantly making inroads in our understanding of pathophysiology, and ins...

    Wei-Wei Liu, Si-Qing Zheng, Tian Li in Signal Transduction and Targeted Therapy (2024)

  9. Article

    Open Access

    Treatment for locally resectable stage IIIC1r cervical cancer: surgery or chemoradiotherapy?

    The aim of this study was to compare the therapeutic value and treatment-related complications of radical hysterectomy with those of concurrent chemoradiotherapy (CCRT) for locally resectable (T1a2–T2a1) stage...

    Mei-ling Zhong, Yin-chuan Liu, Jian-tong Yang, Ya-nan Wang, Mei-hong Ao in BMC Cancer (2024)

  10. Article

    Open Access

    “Moderate” adjuvant chemotherapy-induced leukopenia is beneficial for survival of patients with early breast cancer: a retrospective study

    The association between chemotherapy-induced leukopenia (CIL) and survival for patients with early breast cancer (EBC) is not known. We investigated the relationship between different grades of CIL and surviva...

    Li Wang, Chang Jiang, Na Wang, Yan-Ling Wen, Si-Fen Wang, Cong Xue, **-Wen Bi in BMC Cancer (2023)

  11. Article

    Open Access

    Neoadjuvant nivolumab with or without platinum-doublet chemotherapy based on PD-L1 expression in resectable NSCLC (CTONG1804): a multicenter open-label phase II study

    This prospective multicenter phase II study evaluated the clinical efficacy of neoadjuvant nivolumab-exclusive (N) and nivolumab–chemotherapy (N/C) combinations based on PD-L1 expression. Eligible patients exh...

    Si-Yang Liu, Song Dong, Xue-Ning Yang in Signal Transduction and Targeted Therapy (2023)

  12. Article

    Open Access

    Prognostic implications of alpha-fetoprotein and C-reactive protein elevation in hepatocellular carcinoma following resection (PACE): a large cohort study of 2770 patients

    Routine clinical staging for hepatocellular carcinoma (HCC) incorporates liver function, general health, and tumor morphology. Further refinement of prognostic assessments and treatment decisions may benefit f...

    Kong-Ying Lin, Qing-**g Chen, Shi-Chuan Tang, Zhi-Wen Lin, Jian-** Zhang in BMC Cancer (2023)

  13. Article

    Open Access

    Metatranscriptome of human lung microbial communities in a cohort of mechanically ventilated COVID-19 Omicron patients

    The Omicron variant of the severe acute respiratory syndrome coronavirus 2 (SARS‑CoV‑2) infected a substantial proportion of Chinese population, and understanding the factors underlying the severity of the dis...

    Lin Wang, Jia-Bao Cao, Bin-Bin **a, Yue-Juan Li in Signal Transduction and Targeted Therapy (2023)

  14. Article

    Open Access

    Small extrachromosomal circular DNA harboring targeted tumor suppressor gene mutations supports intratumor heterogeneity in mouse liver cancer induced by multiplexed CRISPR/Cas9

    Primary liver cancer has significant intratumor genetic heterogeneity (IGH), which drives cancer evolution and prevents effective cancer treatment. CRISPR/Cas9-induced mouse liver cancer models can be used to ...

    Tao Guo, Guo-Qiao Chen, Xu-Fan Li, Meng Wang, Kun-Ming Liu in Genome Medicine (2023)

  15. Article

    Open Access

    A model based on adipose and muscle-related indicators evaluated by CT images for predicting microvascular invasion in HCC patients

    The presence of microvascular invasion (MVI) will impair the surgical outcome of hepatocellular carcinoma (HCC). Adipose and muscle tissues have been confirmed to be associated with the prognosis of HCC. We ai...

    **n-Cheng Mao, Shuo Shi, Lun-Jie Yan, Han-Chao Wang, Zi-Niu Ding in Biomarker Research (2023)

  16. Article

    Open Access

    Dynamic single-cell map** unveils Epstein‒Barr virus-imprinted T-cell exhaustion and on-treatment response

    Epstein‒Barr virus (EBV)-associated gastric cancer (GC) manifests an intriguing immunotherapy response. However, the cellular basis for EBV-imprinted tumour immunity and on-treatment response remains undefined...

    Miao-Zhen Qiu, Chaoye Wang, Zhiying Wu, Qi Zhao in Signal Transduction and Targeted Therapy (2023)

  17. Article

    Open Access

    Predicting the outcomes of hepatocellular carcinoma downstaging with the use of clinical and radiomics features

    Downstaging of hepatocellular carcinoma (HCC) makes it possible for patients beyond the criteria to have the chance of liver transplantation (LT) and improved outcomes. Thus, a procedure to predict the prognos...

    Si-Yuan Wang, Kai Sun, Shuo **, Kai-Yu Wang, Nan Jiang, Si-Qiao Shan in BMC Cancer (2023)

  18. Article

    Open Access

    MALAT1/ mir-1-3p mediated BRF2 expression promotes HCC progression via inhibiting the LKB1/AMPK signaling pathway

    The long non-coding RNA metastasis-associated lung adenocarcinoma transcript 1 (MALAT1) has been reported to play a vital role in the occurrence and development of various tumors. However, the underlying mecha...

    Guang-Zhen Li, Guang-**ao Meng, Guo-Qiang Pan, **ao Zhang in Cancer Cell International (2023)

  19. Article

    Open Access

    Soluble CD4 effectively prevents excessive TLR activation of resident macrophages in the onset of sepsis

    T lymphopenia, occurring in the early phase of sepsis in response to systemic inflammation, is commonly associated with morbidity and mortality of septic infections. We have previously shown that a sufficient ...

    Sheng-yuan Zhang, Qiu-** Xu, Li-na Shi in Signal Transduction and Targeted Therapy (2023)

  20. Article

    Open Access

    Nuclear AhR and membranous PD-L1 in predicting response of non-small cell lung cancer to PD-1 blockade

    Si-Chong Han, Gui-Zhen Wang, Ya-Ning Yang in Signal Transduction and Targeted Therapy (2023)

previous disabled Page of 5